Overview

Dry Eye Disease Study With Brimonidine

Status:
Completed

Trial end date:
2018-03-29

Target enrollment:

Participant gender:

Summary

To evaluate the tolerability and preliminary efficacy of Brimonidine eye drops (with and without corticosteroid eye drops) for the treatment of Dry Eye Disease (DED).

Phase:

Phase 2

Details

Lead Sponsor:

Ocugen

Treatments:

Brimonidine Tartrate
Carboxymethylcellulose Sodium
Ophthalmic Solutions